|
Tissue Engineering:
Improving Quality of Life through Biomedicine The Institute for Tissue Engineering and Regenerative Medicine (iTERM) integrates multiple disciplines in biomedical sciences, engineering, and clinical medicine for the development of neuromusculoskeletal tissue engineering and regenerative medicine.
Prof. Rocky S. Tuan’s work on stem cell aims to discover the mechanisms that regulate their regenerative ability to repair and restore function to tissues. He engineered the first three dimensional joint-on-a-chip, called the “microJoint”, to replicate a human joint and was elected fellows of the National Academy of Inventors and the China Association of Inventions for his ground-breaking work. |
Prof. Rocky S. Tuan is widely recognized for his inventions in tissue engineering and regenerative medicine.
|
iTERM engages in multi-disciplinary research on neuromusculoskeletal regeneration.
|
Ground-breaking research led by Prof. Dennis Lo has benefited millions of women globally.
|
Discovery of cell-free fetal DNA in maternal plasma paved way for non-invasive DNA blood tests.
|
Prenatal Diagnosis:
New Horizons in Non-Invasive DNA Tests Prof. Dennis Lo discovered the presence of cell-free fetal DNA in maternal plasma and pioneered a non-invasive DNA blood test for Down syndrome and other genetic diseases. He is also pushing forward the use of a similar approach for screening of early cancers. His work has brought him numerous honours including the King Faisal International Prize in Medicine in 2014 and the Future Science Prize in 2016. |
|
Gastrointestinal Cancer Diagnostics: Novel Discovery for Detecting Malignancies
While Gastrointestinal (GI) cancers account for 40% of overall malignancies in the Chinese population, the traditional biomarkers for GI cancer diagnosis are not very reliable. Prof. Joseph Sung and Prof. Jun Yu have identified new biomarkers for early screening and prognostic predictions of GI cancers, allowing early treatment and reducing cancer mortality. In collaboration with biotechnology companies, non-invasive diagnostic kits for gastric cancer and colorectal cancer have been developed for clinical use.
|
Prof. Joseph Sung’s and Prof. Jun Yu’s work has vastly improved the detection of GI cancers and effectively reduced the associated mortality rate.
|
New biomarkers identified for early screening of GI cancers has led to the development of non-invasive diagnostic kits for clinical use.
|
Prof. H.Y. Edwin Chan’s team is pioneering ways to cure currently incurable neurodegenerative diseases.
|
CUHK’s research in neurodegeneration could lead to the cure of Huntington’s Disease, Spinocerebellar Ataxia, and Amyotrophic Lateral Sclerosis.
|
Neurodegeneration:
Innovating Cures for Rare Diseases Led by Prof. H.Y. Edwin Chan, CUHK’s pioneering research in the development of novel peptidylic and small molecule inhibitors has opened up new horizons in finding cure for rare neurodegenerative diseases which are currently incurable, including Huntington’s Disease, Spinocerebellar Ataxia, and Amyotrophic Lateral Sclerosis. |